Kyle Carver - 09 Nov 2021 Form 4 Insider Report for Kadmon Holdings, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Nov 2021, 16:36:16 UTC
Next SEC filing
05 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Kyle Carver filed Form 4 for Kadmon Holdings, Inc. on 09 Nov 2021.

Key facts

  • This page summarizes Kyle Carver's Form 4 filing for Kadmon Holdings, Inc..
  • 6 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 09 Nov 2021, 16:36.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$2,523,590.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KDMN transaction

Common Stock

Disposed to Issuer

Transaction value
$146,490
Shares
-15,420
Change %
-100%
Price
$9.50
Shares after
0
Date
09 Nov 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KDMN transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$217,800
Shares
-45,000
Change %
-100%
Price
$4.84
Shares after
0
Date
09 Nov 2021
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
45,000
Exercise price
$4.66
Footnotes
F2, F3
KDMN transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$322,300
Shares
-55,000
Change %
-100%
Price
$5.86
Shares after
0
Date
09 Nov 2021
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
55,000
Exercise price
$3.64
Footnotes
F2, F3
KDMN transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$351,500
Shares
-50,000
Change %
-100%
Price
$7.03
Shares after
0
Date
09 Nov 2021
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
50,000
Exercise price
$2.47
Footnotes
F2, F3
KDMN transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$516,000
Shares
-100,000
Change %
-100%
Price
$5.16
Shares after
0
Date
09 Nov 2021
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
100,000
Exercise price
$4.34
Footnotes
F2, F3
KDMN transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$969,500
Shares
-175,000
Change %
-100%
Price
$5.54
Shares after
0
Date
09 Nov 2021
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount
175,000
Exercise price
$3.96
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Kyle Carver is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").

Footnote F2

In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option.

Footnote F3

Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .